Gene · 7913
Papers1,526
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,526
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pediatric lacrimal sac non-keratinizing squamous cell carcinoma with DEK-AFF2 gene fusion: clinical and histopathological case report. | Orbit | 2026 | 41431306 | PubTator, text mining | PubMed |
| Genomic landscape of paired primary and peritoneal metastatic lesions in gastric cancer highlights evolutionary dynamics and mutational drivers. | J Adv Res | 2026 | 40436141 | PubTator, text mining | PubMed |
| Resistance mechanism to pembrolizumab in DEK-AFF2 fusion-associated sinonasal squamous cell carcinoma. | Int Cancer Conf J | 2025 | 41395570 | PubTator, text mining | PubMed |
| Clinical Features and Prognosis Analysis of Acute Myeloid Leukemia in Children with DEK-CAN-Positive. | Clin Lab | 2025 | 41362194 | PubTator, text mining | PubMed |
| Proteomic discovery of DEK and NUMA1 as new players in UV-induced DNA damage repair mechanisms. | Cell Death Discov | 2025 | 41285742 | PubTator, text mining | PubMed |
| [Characterization of Acute Myeloid Leukemia Patients with DEK-NUP214 Fusion Gene Positive]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 41234076 | PubTator, text mining | PubMed |
| Targeting c-Myc enhances immunotherapy efficacy in combination with Ras inhibitor in triple-negative breast cancer. | Clin Transl Med | 2025 | 41020311 | PubTator, text mining | PubMed |
| NUP214 in Acute Myeloid Leukemia. | Cells | 2025 | 41002427 | PubTator, text mining | PubMed |
| Implications of canonical histone H3.1 and histone variant H3.3 in cancer. | Open Biol | 2025 | 40987316 | PubTator, text mining | PubMed |
| Post-translational modification of H2B C-terminal helix regulates nucleosome interactions and chromatin signaling. | Nucleic Acids Res | 2025 | 40966523 | PubTator, text mining | PubMed |
| DEK-NUP214 monitoring before and after allogeneic haematopoietic stem cell transplantation for acute myeloid leukemia: A report from the TROPHY study group. | J Transl Int Med | 2025 | 40861068 | PubTator, text mining | PubMed |
| DEK Interacts with IRE1α to Modulate Endoplasmic Reticulum Stress in Deoxynivalenol-Induced Intestinal Inflammation. | J Agric Food Chem | 2025 | 40802874 | PubTator, text mining | PubMed |
| Research Progress on Glycolysis in the Pathogenesis of Asthma. | J Asthma Allergy | 2025 | 40746369 | PubTator, text mining | PubMed |
| DEK facilitates bortezomib resistance of multiple myeloma by modulating ferroptosis. | Clin Exp Med | 2025 | 40673987 | PubTator, text mining | PubMed |
| SOX4 as a Key Oncogene Driving Tumor Invasion in Retinoblastoma. | Invest Ophthalmol Vis Sci | 2025 | 40402518 | PubTator, text mining | PubMed |
| Clinicopathological insights and prognostic implications of DEK in association with apoptosis-regulating factors in ovarian cancer. | Clin Transl Oncol | 2025 | 40392449 | PubTator, text mining | PubMed |
| DEK::AFF2-Associated Papillary Squamous Cell Carcinoma of the Sinonasal Tract: Clinicopathologic Characterization of 9 Cases. | Head Neck Pathol | 2025 | 40392381 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies tRNA modification enzyme CTU2 as a novel tumor biomarker and its role in immune microenvironment. | Front Immunol | 2025 | 40375999 | PubTator, text mining | PubMed |
| The oncoprotein DEK controls growth-regulated gene expression by enhancing the DNA-binding activity of basic leucine zipper transcription factors. | FEBS J | 2025 | 40318137 | PubTator, text mining | PubMed |
| Sporadic late onset nemaline myopathy responsive to plasma exchanges discovered during a Graft-versus-host disease. | Neuromuscul Disord | 2025 | 40311393 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7913/papers?page=2